Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,743
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
for
Indolent Systemic Mastocytosis
Location: Ann Arbor MI, Normal IL, Wheaton MD, St Louis MO,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07264959
Recruiting
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
for
Breast Lumpectomy, Laparoscopic Cholecystectomy,
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT06934564
Recruiting
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
for
Chondral Defect, Osteochondritis Dissecans (OCD),
Location: Ann Arbor MI, Akron OH, Columbus OH, Milwaukee WI,
Sponsor: Vericel Corporation
Sex: All
Age: 10 - 17
Code: NCT03588975
Phase3, Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
for
Primary Myelofibrosis,
Location: Ann Arbor MI, Nashville TN, New York NY, Toronto,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06517875
Phase2, Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Location: Ann Arbor MI, Chicago IL, Cincinnati OH, Pittsburgh PA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05878717
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Ann Arbor MI, Detroit MI, Cleveland OH, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
for
Pain, Sickle Cell Disease
Location: Ann Arbor MI, Chicago IL, Pittsburgh PA, Rochester NY,
Sponsor: University of Pittsburgh
Sex: All
Age: 16 - 30
Code: NCT06374238
Recruiting
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Ann Arbor MI, Detroit MI, Warren MI, London, Bexley OH,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07474792
Phase2, Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia (APL),
Location: Ann Arbor MI, Columbus OH, Buffalo NY, Lexington KY,
Sponsor: Quetzal Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07504458
Phase3, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Ann Arbor MI, Canton OH, Columbus OH, Chicago IL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase3, Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
for
CLL/SLL
Location: Ann Arbor MI, Peoria IL, Richmond VA, Greenville NC,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT06104566
Phase3, Recruiting
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
for
Bladder Cancer, Non-muscle Invasive Bladder Cancer
Location: Ann Arbor MI, New Brunswick NJ, Tampa FL, Vancouver
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT07144319
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Ann Arbor MI, Chicago IL, Milwaukee WI, Pittsburgh PA,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase3, Recruiting
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
for
B-cell Mediated Autoimmune Disorders
Location: Ann Arbor MI, Cleveland OH, Columbus OH, Milwaukee WI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06680037
Phase1, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Ann Arbor MI, Farmington MI, Detroit MI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05890352
Phase2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 60+
Code: NCT07437950
Phase2, Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07383441
Phase3, Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Ypsilanti MI, Ann Arbor MI, Canton MI, Chelsea MI,